Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Goodwill & Intangibles (2010 - 2026)

Cel Sci (CVM) posted Goodwill & Intangibles of $73000.0 for Q1 2026, down 28.43% sequentially from $102000.0 in Q4 2025, and down 48.23% YoY from $141000.0 in Q1 2025.

Cel Sci (CVM) Goodwill & Intangibles (2010 - 2026) Analysis & Trends

Cel Sci has reported Goodwill & Intangibles for 16 years, with the latest figure at $73000.0 in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 48.23% year-over-year to $73000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73000.0 (down 48.23% YoY) and the FY2025 annual result came in at $119856.0, down 27.58% from the prior year.
  • Goodwill & Intangibles declined to $73000.0 in Q1 2026 per CVM's latest filing, from $102000.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $234658.0 in Q1 2022 and troughed at $73000.0 in Q1 2026.
  • A 5-year average of $168570.5 and a median of $180482.0 in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles decreased 5.45% in 2024, then plunged 48.23% in 2026.
  • Over 5 years, Goodwill & Intangibles stood at $202000.0 in 2022, then dropped by 6.93% to $188000.0 in 2023, then slipped by 21.28% to $148000.0 in 2024, then slumped by 31.08% to $102000.0 in 2025, then declined by 28.43% to $73000.0 in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $73000.0, $102000.0, and $119856.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Cel Sci 2.12 Mn -4.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 73,000.00
Dec 31, 2025 102,000.00
Sep 30, 2025 119,856.00
Jun 30, 2025 130,585.00
Mar 31, 2025 141,000.00
Dec 31, 2024 148,000.00
Sep 30, 2024 165,492.00
Jun 30, 2024 173,028.00
Mar 31, 2024 180,482.00
Dec 31, 2023 188,000.00
Sep 30, 2023 197,704.00
Jun 30, 2023 183,000.00
Mar 31, 2023 192,231.00
Dec 31, 2022 202,000.00
Sep 30, 2022 212,201.00
Jun 30, 2022 222,462.00
Mar 31, 2022 234,658.00
Dec 31, 2021 247,521.00
Sep 30, 2021 275,866.00
Jun 30, 2021 279,366.00